Abstract: A light-emitting device of the present disclosure includes: at least one first semiconductor layer of one conductivity type; a plurality of active layers laminated on the first semiconductor layer; a plurality of second semiconductor layers of another conductivity type, the plurality of second semiconductor layers being laminated on the plurality of active layers; and a plurality of electrodes connected to the at least one first semiconductor layer and the plurality of second semiconductor layers. Some electrodes of the plurality of electrodes are opposed to each other, with the plurality of active layers lying in between, and the other electrodes of the plurality of electrodes are located in a region between the some electrodes of the plurality of electrodes.

Abstract: An object of the present invention is to provide a recombinant LPA phosphatase capable of specifically hydrolyzing LPA, which is useful for elucidation of the metabolism pathway of LPA, and also for diagnosis and treatment of various diseases with which LPA is associated; a method capable of simply and inexpensively determining LPA associated with various diseases; and a kit for determination suitable for the method. The present invention has succeeded in purifying the LPA phosphatase using bovine brain as raw material, and further in cloning human LPA phosphatase gene.

Abstract: The present invention provides a lysophospholipid of the formula (I) 1

Abstract: An object of the present invention is to provide a recombinant LPA phosphatase capable of specifically hydrolyzing LPA, which is useful for elucidation of the metabolism pathway of LPA, and also for diagnosis and treatment of various diseases with which LPA is associated; a method capable of simply and inexpensively determining LPA associated with various diseases; and a kit for determination suitable for the method. The present invention has succeeded in purifying the LPA phosphatase using bovine brain as a raw material, and further in cloning human LPA phosphatase gene.

Abstract: An object of the present invention is to provide a recombinant LPA phosphates capable of specifically hydrolyzing LPA, which is useful for elucidation of the metabolic pathway of LPA, and also for diagnosis and treatment of various diseases with which LPA is associated. The present invention also provides for a method capable of simply and inexpensively determining LPA associated with various diseases. The present invention also provides for a kit for determination suitable for the method. The present invention has succeeded in purifying the LPA phosphatase using bovine brain as a raw material, and further in cloning human LPA phosphatase gene.